DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.

Author(s): Burgio KL, Goode PS, Richter HE, Markland AD, Johnson TM 2nd, Redden DT

Affiliation(s): Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research Education and Clinical Center, Birmingham, Alabama and Atlanta, Georgia, USA. kburgio@aging.uab.edu

Publication date & source: 2010-08, J Urol., 184(2):598-603. Epub 2010 Jun 19.

Publication type: Comparative Study; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.

PURPOSE: We tested whether individualized drug therapy enhanced with behavioral training would result in better outcomes than individualized drug therapy alone. MATERIALS AND METHODS: Participants were community dwelling women with urge predominant incontinence. Using a randomized clinical trial design women were randomized to 8 weeks (4 visits) of drug therapy alone (32) or drug therapy plus behavioral training (32). Drug therapy was individually titrated, extended release oxybutynin with proactive management of side effects. Behavioral training included pelvic floor muscle training and urge suppression techniques. The primary outcome measure was reduction in frequency of incontinence episodes on bladder diary at 8 weeks (with followup at 6 and 12 months). Secondary outcomes included patient satisfaction, global perception of improvement, Urogenital Distress Inventory and Incontinence Impact Questionnaire. RESULTS: In intent to treat analysis frequency of incontinence was reduced a mean of 88.5% in the drug alone group and 78.3% in the combined therapy group (p = 0.16). Outcomes were not significantly different between the groups in the analysis of completers (91.5% vs 86.2%, p = 0.34), or in either analysis at 6 or 12 months. The groups also did not differ significantly on secondary outcomes at any point. Participants in the drug alone group tended to be taking higher doses of oxybutynin at 8 weeks but the final dose did not differ significantly between the groups. Based on a conditional power calculation the trial was stopped early for futility. CONCLUSIONS: When drug therapy is implemented with frequent individualized dose titration, daily bladder diaries and careful management of side effects, initiating concurrent behavioral training does not enhance outcomes for urge incontinence in women. Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Page last updated: 2010-10-05

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017